Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1040

1.

Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion.

Ho CH, Chen CL, Li WY, Chen CJ.

Carcinogenesis. 2009 Aug;30(8):1443-51. doi: 10.1093/carcin/bgp135. Epub 2009 May 29.

PMID:
19483191
3.
4.

Nuclear factor-Y and Epstein Barr virus in nasopharyngeal cancer.

Chia MC, Leung A, Krushel T, Alajez NM, Lo KW, Busson P, Klamut HJ, Bastianutto C, Liu FF.

Clin Cancer Res. 2008 Feb 15;14(4):984-94. doi: 10.1158/1078-0432.CCR-07-0828.

5.

Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma.

Kong QL, Hu LJ, Cao JY, Huang YJ, Xu LH, Liang Y, Xiong D, Guan S, Guo BH, Mai HQ, Chen QY, Zhang X, Li MZ, Shao JY, Qian CN, Xia YF, Song LB, Zeng YX, Zeng MS.

PLoS Pathog. 2010 Jun 3;6(6):e1000940. doi: 10.1371/journal.ppat.1000940.

6.

Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells.

Lo AK, Lo KW, Tsao SW, Wong HL, Hui JW, To KF, Hayward DS, Chui YL, Lau YL, Takada K, Huang DP.

Neoplasia. 2006 Mar;8(3):173-80.

7.

Induction of matrix metalloproteinases by Epstein-Barr virus latent membrane protein 1 isolated from nasopharyngeal carcinoma.

Lee DC, Chua DT, Wei WI, Sham JS, Lau AS.

Biomed Pharmacother. 2007 Oct;61(9):520-6. Epub 2007 Sep 14.

PMID:
17913445
8.
9.

Epstein-Barr virus transcription activator Rta upregulates decoy receptor 3 expression by binding to its promoter.

Ho CH, Hsu CF, Fong PF, Tai SK, Hsieh SL, Chen CJ.

J Virol. 2007 May;81(9):4837-47. Epub 2007 Feb 14.

10.

Induction of interleukin-8 by Epstein-Barr virus latent membrane protein-1 and its correlation to angiogenesis in nasopharyngeal carcinoma.

Yoshizaki T, Horikawa T, Qing-Chun R, Wakisaka N, Takeshita H, Sheen TS, Lee SY, Sato H, Furukawa M.

Clin Cancer Res. 2001 Jul;7(7):1946-51.

11.
13.

Transformation of Madin-Darby canine kidney (MDCK) epithelial cells by Epstein-Barr virus latent membrane protein 1 (LMP1) induces expression of Ets1 and invasive growth.

Kim KR, Yoshizaki T, Miyamori H, Hasegawa K, Horikawa T, Furukawa M, Harada S, Seiki M, Sato H.

Oncogene. 2000 Mar 30;19(14):1764-71.

14.

NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.

Verhoeven RJ, Tong S, Zhang G, Zong J, Chen Y, Jin DY, Chen MR, Pan J, Chen H.

J Virol. 2016 Jun 24;90(14):6475-88. doi: 10.1128/JVI.00613-16. Print 2016 Jul 15.

15.

Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.

Zhong BL, Zong YS, Lin SX, Zhang M, Liang YJ.

Ai Zheng. 2006 Feb;25(2):136-42.

PMID:
16480574
16.

Epstein-Barr virus latent membrane protein 1 (LMP1) upregulates Id1 expression in nasopharyngeal epithelial cells.

Li HM, Zhuang ZH, Wang Q, Pang JC, Wang XH, Wong HL, Feng HC, Jin DY, Ling MT, Wong YC, Eliopoulos AG, Young LS, Huang DP, Tsao SW.

Oncogene. 2004 May 27;23(25):4488-94.

PMID:
15064751
17.
18.

In nasopharyngeal carcinoma cells, Epstein-Barr virus LMP1 interacts with galectin 9 in membrane raft elements resistant to simvastatin.

Pioche-Durieu C, Keryer C, Souquère S, Bosq J, Faigle W, Loew D, Hirashima M, Nishi N, Middeldorp J, Busson P.

J Virol. 2005 Nov;79(21):13326-37.

19.
20.

Epstein-Barr virus LMP1 modulates the malignant potential of gastric carcinoma cells involving apoptosis.

Sheu LF, Chen A, Wei YH, Ho KC, Cheng JY, Meng CL, Lee WH.

Am J Pathol. 1998 Jan;152(1):63-74.

Supplemental Content

Support Center